Clinical Trial Update: A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy [Phase 1]

View source ↗

Summary

A Phase 1, non-randomized study evaluating the safety of adding anakinra to standard chemotherapy in pancreatic cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Anakinra (anakinra)
• Standard chemotherapy (regimen not specified)

Snippet

Sponsor: Baylor Research Institute | Conditions: Pancreas Cancer | Phase 1 | Status: COMPLETED